Absolute numbers of circulating leukocytes in different clinical groups
| . | HC . | HUS . | UC . | IC . |
|---|---|---|---|---|
| No. patients | 21 | 31 | 20 | 17 |
| WBC count, × 109/L | 8.55 ± 2.71 | 17.06 ± 6.65* | 12.35 ± 5.42 | 20.56 ± 11.87* |
| Monocytes, % | 4.57 ± 1.63 | 7.30 ± 3.28* | 6.58 ± 3.16†‡ | 7.74 ± 2.71* |
| Monocytes, × 109/L | 0.40 ± 0.23 | 1.26 ± 0.77* | 0.70 ± 0.0.39§ | 1.50 ± 1.27* |
| Lymphocytes, × 109/L | 3.26 ± 1.22 | 5.14 ± 2.42§ | 3.20 ± 1.46‖ | 4.97 ± 5.00 |
| NK cells, × 109/L | 0.29 ± 0.16 | 0.20 ± 0.05† | 0.30 ± 0.06 | 0.64 ± 0.26 |
| NKdim, × 109/L | 0.18 ± 0.12 | 0.09 ± 0.08 | 0.22 ± 0.09 | 0.55 ± 0.60 |
| NKbright, × 109/L | 0.02 ± 0.02 | 0.04 ± 0.03 | 0.02 ± 0.01 | 0.04 ± 0.02 |
| . | HC . | HUS . | UC . | IC . |
|---|---|---|---|---|
| No. patients | 21 | 31 | 20 | 17 |
| WBC count, × 109/L | 8.55 ± 2.71 | 17.06 ± 6.65* | 12.35 ± 5.42 | 20.56 ± 11.87* |
| Monocytes, % | 4.57 ± 1.63 | 7.30 ± 3.28* | 6.58 ± 3.16†‡ | 7.74 ± 2.71* |
| Monocytes, × 109/L | 0.40 ± 0.23 | 1.26 ± 0.77* | 0.70 ± 0.0.39§ | 1.50 ± 1.27* |
| Lymphocytes, × 109/L | 3.26 ± 1.22 | 5.14 ± 2.42§ | 3.20 ± 1.46‖ | 4.97 ± 5.00 |
| NK cells, × 109/L | 0.29 ± 0.16 | 0.20 ± 0.05† | 0.30 ± 0.06 | 0.64 ± 0.26 |
| NKdim, × 109/L | 0.18 ± 0.12 | 0.09 ± 0.08 | 0.22 ± 0.09 | 0.55 ± 0.60 |
| NKbright, × 109/L | 0.02 ± 0.02 | 0.04 ± 0.03 | 0.02 ± 0.01 | 0.04 ± 0.02 |
Data are expressed as means ± SD. NK cell studies were performed on a lesser number of patients: HC (n = 18), HUS (n = 16), UC (n = 9), and IC (n = 8).
WBC indicates white blood cells.
P < .001 compared with HC.
P < .05 compared with HC.
P < .01 compared with HUS.
P < .005 compared with HC.
P < .005 compared with HUS.